NL7308876A - - Google Patents

Info

Publication number
NL7308876A
NL7308876A NL7308876A NL7308876A NL7308876A NL 7308876 A NL7308876 A NL 7308876A NL 7308876 A NL7308876 A NL 7308876A NL 7308876 A NL7308876 A NL 7308876A NL 7308876 A NL7308876 A NL 7308876A
Authority
NL
Netherlands
Application number
NL7308876A
Other versions
NL175910B (nl
NL175910C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7308876A publication Critical patent/NL7308876A/xx
Publication of NL175910B publication Critical patent/NL175910B/xx
Application granted granted Critical
Publication of NL175910C publication Critical patent/NL175910C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C07D233/08—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms
    • C07D233/12—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D233/14—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NLAANVRAGE7308876,A 1972-06-27 1973-06-26 Werkwijze voor het bereiden van anti-inflammatoir, antipyretisch en/of analgetisch werkzame esters van 2-(6-methoxy-2-naftyl)-propionzuur, werkwijze ter bereiding van farmaceutische preparaten en de door toepassing daarvan verkregen gevormde voortbrengselen. NL175910C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26664072A 1972-06-27 1972-06-27

Publications (3)

Publication Number Publication Date
NL7308876A true NL7308876A (fr) 1974-01-02
NL175910B NL175910B (nl) 1984-08-16
NL175910C NL175910C (nl) 1985-01-16

Family

ID=23015387

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7308876,A NL175910C (nl) 1972-06-27 1973-06-26 Werkwijze voor het bereiden van anti-inflammatoir, antipyretisch en/of analgetisch werkzame esters van 2-(6-methoxy-2-naftyl)-propionzuur, werkwijze ter bereiding van farmaceutische preparaten en de door toepassing daarvan verkregen gevormde voortbrengselen.

Country Status (13)

Country Link
JP (1) JPS5438097B2 (fr)
AT (1) AT323145B (fr)
AU (1) AU472375B2 (fr)
BE (1) BE801440A (fr)
CA (1) CA1012159A (fr)
CH (1) CH581605A5 (fr)
DE (1) DE2331665C2 (fr)
ES (1) ES416311A1 (fr)
FR (1) FR2190451B1 (fr)
GB (1) GB1377316A (fr)
IL (1) IL42472A (fr)
NL (1) NL175910C (fr)
ZA (1) ZA733992B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1508988A (en) * 1987-04-27 1988-10-27 Syntex Pharmaceuticals International Ltd. Omega-quaternary ammonium alkyl esters and thioesters of acidic nonsteroidal antiinflammatory drugs
WO2008020270A1 (fr) * 2006-08-15 2008-02-21 Techfields Biochem Co. Ltd Promédicaments hydrosolubles chargés positivement contenant des acides aryl- et hétéroarylpropioniques et dotés d'une très grande vitesse de pénétration cutanée
KR101366296B1 (ko) * 2012-03-07 2014-02-21 주식회사 포스코 내화재 축조 방법
JP6290947B2 (ja) * 2016-02-05 2018-03-07 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚透過率を有するアリール−及びヘテロアリールプロピオン酸の正荷電水溶性プロドラッグ

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE328274B (fr) * 1963-05-02 1970-09-14 Parke Davis & Co
ZA701191B (en) * 1969-03-24 1971-09-29 Syntex Corp 2-(6-substituted-2'-naphthyl)acetic acid esters and process for producing same

Also Published As

Publication number Publication date
IL42472A (en) 1977-01-31
NL175910B (nl) 1984-08-16
GB1377316A (en) 1974-12-11
AU472375B2 (en) 1976-05-20
AT323145B (de) 1975-06-25
ZA733992B (en) 1975-01-29
DE2331665C2 (de) 1983-04-21
JPS5438097B2 (fr) 1979-11-19
NL175910C (nl) 1985-01-16
CA1012159A (en) 1977-06-14
IL42472A0 (en) 1973-08-29
AU5690373A (en) 1974-12-19
JPS504053A (fr) 1975-01-16
ES416311A1 (es) 1976-05-16
BE801440A (fr) 1973-12-26
DE2331665A1 (de) 1974-01-17
CH581605A5 (fr) 1976-11-15
FR2190451A1 (fr) 1974-02-01
FR2190451B1 (fr) 1976-12-31

Similar Documents

Publication Publication Date Title
FR2167852A1 (fr)
FR2196537B1 (fr)
FR2190451B1 (fr)
JPS4967879U (fr)
CS169847B2 (fr)
JPS4923280A (fr)
FR2193583B1 (fr)
JPS5111569Y2 (fr)
JPS5436647Y2 (fr)
JPS5221758Y2 (fr)
JPS4937749A (fr)
FR2184768A1 (fr)
JPS49135201A (fr)
JPS4888817A (fr)
CS168920B1 (fr)
CS168649B2 (fr)
CS163015B1 (fr)
CS165652B1 (fr)
CS153284B1 (fr)
CS163952B1 (fr)
CH576730A5 (fr)
CH576684A5 (fr)
CH1200672A4 (fr)
CH563258A5 (fr)
CH563273A5 (fr)

Legal Events

Date Code Title Description
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee
V1 Lapsed because of non-payment of the annual fee